Lucid Diligence Brief: Kardigan $254m Series B
Lucid Diligence Brief: Kardigan $254m Series B Professional audiences only. Not…
Lucid Diligence Brief: Samsung and GRAIL LOI, Galleri MCED rollout in Asia
Lucid Diligence Brief: Samsung and GRAIL LOI, Galleri MCED rollout in Asia…
Lucid Diligence Brief: Nabla Bio and Takeda, second AI protein-design collaboration
Lucid Diligence Brief: Nabla Bio and Takeda, second AI protein-design…
Lucid Diligence Brief: Tubulis €308m Series C, NaPi2b ADC TUB-040
Lucid Diligence Brief: Tubulis €308m Series C, NaPi2b ADC TUB-040 Professional…
Lucid Diligence Brief: Verily UCHealth AI collaboration
Lucid Diligence Brief: Verily UCHealth AI collaboration Professional audiences…
Lucid Diligence Brief: Kailera Therapeutics $600m Series B
Lucid Diligence Brief: Kailera Therapeutics $600m Series B Professional…
Lucid Diligence Brief: Ascenta Capital Fund I, $325M final close
Lucid Diligence Brief: Ascenta Capital Fund I, $325M final close Professional…
Lucid Diligence Brief: Bristol Myers Squibb's acquisition of Orbital Therapeutics
Lucid Diligence Brief: Bristol Myers Squibb's acquisition of Orbital…